---
title: "CE mark approval for Biosensors’ Imperia THV delivery system"
date: "2025-07-14T11:20:18.000Z"
publishedDate: "14 juillet 2025"
summary: "Biosensors International has received CE mark certification for the Imperia delivery system under the EU Medical Device Regulation (MDR). The Imperia delivery system is part of the Allegra transcatheter heart valve (THV) system and is intended for the transfemoral implantation of the already CE-marked Allegra THV, indicated for the treatment of severe aortic stenosis."
importance: ""
sourceUrl: "https://cardiovascularnews.com/ce-mark-approval-for-biosensors-imperia-thv-delivery-system/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-07-14-ce-mark-approval-for-biosensors-imperia-thv-delivery-system"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/07/SN-PostCEMark_d2_1920x1080_WBG_HR300dpi.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/ce-mark-approval-for-biosensors-imperia-thv-delivery-system/"
---

![CE mark approval for Biosensors’ Imperia THV delivery system](https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/07/SN-PostCEMark_d2_1920x1080_WBG_HR300dpi.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/ce-mark-approval-for-biosensors-imperia-thv-delivery-system/*

## L’essentiel

Biosensors International has received CE mark certification for the Imperia delivery system under the EU Medical Device Regulation (MDR). The Imperia delivery system is part of the Allegra transcatheter heart valve (THV) system and is intended for the transfemoral implantation of the already CE-marked Allegra THV, indicated for the treatment of severe aortic stenosis.

## Lien source

https://cardiovascularnews.com/ce-mark-approval-for-biosensors-imperia-thv-delivery-system/
